site stats

Btai stock price target

WebApr 6, 2024 · According to 16 analysts, the average rating for BTAI stock is "Buy." The 12-month stock price forecast is $54.52, which is an increase of 215.51% from the latest …

BioXcel Therapeutics (BTAI) Price To Free Cash Flow

WebApr 10, 2024 · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $46.00, a 168.8% upside from current levels. In a report issued on April 6, Mizuho... WebMar 22, 2024 · Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,001.09(-0.04%) DOW 32,486.38(-0.23%) QQQ 311.07(+0.24%) AAPL 160.03(+0.47%) MSFT 277.05(+1.19%) META 204.05(+0.93%) GOOGL 105.30(+0.36%) AMZN 100.19(-0.42%) … ez media iptv https://coberturaenlinea.com

BioXcel Therapeutics - BTAI Stock Forecast, Price & News

WebPrice To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for BioXcel Therapeutics (BTAI) WebApr 10, 2024 · Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $50.00. BioXCel Therapeutics (NASDAQ:BTAI) A Hot Buy That Confuses Analysts WebBTAI: Get the latest BioXcel Therapeutics stock price and detailed information including BTAI news, historical charts and realtime prices. higuain juventus transfermarkt

Bioxcel Therapeutics (BTAI) Stock Forecast & Price Target - TipRanks

Category:BTAI: Average Analyst Price Target is $75 - StockNews

Tags:Btai stock price target

Btai stock price target

Bioxcel Therapeutics (BTAI) Stock Price & Analysis

WebStock Price Forecast The 10 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 49.00, with a high estimate of 75.00 and a low … WebApr 12, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction dated Thursday, April 6th. The shares were sold at an average price of $17.32, for a total transaction of $1,039,200.00.

Btai stock price target

Did you know?

WebWhat is BTAI's Price Target? According to 6 Wall Street analyst s that have issued a 1 year BTAI price target, the average BTAI price target is $42.17 , with the highest BTAI … WebBTAI has a higher average analyst price target than 2939.86% of stocks in the small market cap category. In the context of stocks in the small market cap category, BIOXCEL …

WebApr 12, 2024 · Shares of BTAI stock opened at $17.35 on Wednesday. BioXcel Therapeutics, Inc. has a one year low of $8.80 and a one year high of $34.13. ... Finally, … WebBioXcel Therapeutics (NASDAQ:BTAI) had a huge reversal on big volume Thursday, popping 1.95, or 81%, to 4.36, on 2.7 million shares and closed at the upper end of the... BioXcel Therapeutics...

WebApr 12, 2024 · The average twelve-month price prediction for Carnival Co. & is $11.58 with a high price target of $18.00 and a low price target of $7.00. Do Wall Street analysts like Carnival Co. & more than its competitors? Analysts like Carnival Co. & less than other Consumer Discretionary companies. WebApr 9, 2024 · BTAI Price Target 2024 BioXcel Therapeutics Analyst Ratings NASDAQ:BTAI BioXcel Therapeutics - BTAI Price Target & Analyst Ratings $18.66 +0.06 (+0.32%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $18.34 $19.27 50 …

WebApr 10, 2024 · BioXcel Therapeutics Stock Performance Shares of NASDAQ:BTAI opened at $17.28 on Monday. The business’s 50 day moving average price is $25.69 and its 200-day moving average price is $20.40....

WebFind real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ez medz mt morrisWebMar 24, 2024 · According to 16 stock analysts, the average 12-month stock price forecast for BTAI stock is $ 57.03 , which predicts an increase of 211.30%. The lowest target is … ezmegazWebApr 11, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction that occurred on Thursday, April 6th. The... higuain memeWebJul 26, 2024 · Recently, the Street’s analysts have tapped three stocks they see as long-term winners – but with low share value right now. According to TipRanks' database, these are Strong Buy stocks, featuring... higuain miamiWebApr 11, 2024 · BTAI has been the topic of several research reports. The Goldman Sachs Group raised their price target on shares of BioXcel Therapeutics from $16.00 to $26.00 and gave the company a “neutral ... ez meetsWebApr 6, 2024 · The price target raised to $80 per share is four times as large as the last closing price. BXCL501, the treatment identified as Igalmi after its FDA approval, is … ez megWebBTAI U.S.: Nasdaq BioXcel Therapeutics Inc. Watch list Create BTAI Alert After Hours Last Updated: Apr 3, 2024 4:49 p.m. EDT Delayed quote $ 19.10 0.00 0.00% After Hours … higuain napoli transfermarkt